天音控股(000829.SZ)2020年度淨利潤預增215.66%-274.85%
格隆匯 1 月 4日丨天音控股(000829.SZ)公佈,預計2020年年度歸屬於上市公司股東的淨利潤1.6億元-1.9億元,同比增長215.66%-274.85%。
報吿期內,公司預計營業收入590 億元~600 億元,比去年同期增長11.44%~13.33%,主要系公司線上新業務模式開展和海外業務穩步拓張所致。
報吿期內,公司非經常性損益約1.8 億元,主要系轉讓贛州長江實業有限責任公司95%股權和江西章貢酒業有限責任公司95%股權,及2017年發行股份購買資產交易對方業績補償所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.